rethinkTHC Search
Menu
Study breakdown

Cannabis smoking linked to oral bacteria that caused brain changes in mice

ObservationalPreliminary evidence
The takeaway

Chronic cannabis smokers harbored elevated levels of the oral bacterium Actinomyces meyeri, which when fed to mice for six months decreased activity, increased brain macrophage infiltration, and boosted amyloid-beta production.

Neuroscience researchers, oral health professionals, and anyone interested in how cannabis smoking might affect the brain through unexpected pathways.

First study linking cannabis-associated oral bacteria to brain amyloid-beta production

What the researchers found

Cannabis smokers showed oral microbial dysbiosis with increased Streptococcus and Actinomyces and decreased Neisseria. Mice orally exposed to the cannabis-enriched bacterium Actinomyces meyeri for six months showed decreased global activity, increased macrophage brain infiltration, and increased beta-amyloid 42 protein production.

Why it matters

This is the first study to connect cannabis-associated changes in oral bacteria to potential neurological consequences, suggesting a novel pathway by which chronic cannabis smoking might affect brain health.

The numbers in context

16 cannabis smokers vs 27 controls; mice inoculated twice weekly for 6 months; Actinomyces meyeri enrichment inversely associated with age of first cannabis use; increased beta-amyloid 42 production in mouse brains

How the study worked

Researchers compared saliva microbiomes of 16 chronic cannabis smokers with cannabis use disorder and 27 non-smoking controls using 16S rRNA sequencing. Then mice were orally inoculated with Actinomyces meyeri, Actinomyces odontolyticus, or Neisseria elongata twice weekly for six months to test functional effects.

What this study cannot tell us

Very small human sample (16 vs 27). Mouse model may not replicate human oral-brain pathways. Cannot determine whether cannabis itself or combustion byproducts caused the microbial changes. No control for tobacco co-use.

How to read the evidence

Novel translational study combining human microbiome data with animal experiments, but very small human sample and animal-to-human extrapolation limits conclusions.

When this study was published

Published in 2021.

The bigger picture

The oral microbiome-brain axis is an emerging area of research. This study adds cannabis smoking as a factor that may reshape oral bacteria in ways that have downstream neurological consequences, though the pathway from human observation to mouse experiment needs further validation.

Questions still open

  • Do non-smoked forms of cannabis produce the same oral microbial changes? Is this pathway relevant to human neurodegenerative disease risk? Could oral hygiene interventions mitigate these effects in cannabis smokers?

Common questions

Does this mean cannabis causes Alzheimer's?
No. This study found a specific oral bacterium enriched in cannabis smokers that increased amyloid-beta in mice. Whether this translates to Alzheimer's risk in humans is unknown and would require much more research.
Was it the cannabis or the smoking?
The study cannot distinguish between effects of cannabis compounds and effects of smoke inhalation on oral bacteria. Non-smoked cannabis was not tested.

Read the original research

Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.

EBioMedicine, 74, 103701

Citation

Luo, Zhenwu; Fitting, Sylvia; Robinson, Catrina; Benitez, Andreana; Li, Min; Wu, Yongxia; Fu, Xiaoyu; Amato, Davide; Ning, Wangbin; Funderburg, Nicholas; Wang, Xu; Zhou, Zejun; Yu, Xuezhong; Wagner, Amanda; Cong, Xiaomei; Xu, Wanli; Maas, Kendra; Wolf, Bethany J; Huang, Lei; Yu, Jeremy; Scott, Alison; Mcrae-Clark, Aimee; Hamlett, Eric D; Jiang, Wei. (2021). Chronic cannabis smoking-enriched oral pathobiont drives behavioral changes, macrophage infiltration, and increases β-amyloid protein production in the brain.. EBioMedicine, 74, 103701. https://doi.org/10.1016/j.ebiom.2021.103701

Explore the wider topic